Indicators

Latest News about BPMC

Recent news which mentions BPMC

< Previous 1 2 3 4 5 Next >

IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday

October 26, 2023

Blueprint Medicines's Earnings: A Preview

October 25, 2023

Unpacking Blueprint Medicines' Ayvakit's Bright Future: Insights From Latest Physician Survey On Sales Predictions

August 21, 2023

Analyst Ratings for Blueprint Medicines

August 21, 2023

What 15 Analyst Ratings Have To Say About Blueprint Medicines

August 02, 2023

Why Shares of Blueprint Medicines Are Falling Wednesday

August 02, 2023

A Preview Of Blueprint Medicines's Earnings

August 01, 2023

Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023

July 31, 2023

3 Biotech Stocks Using AI to Change Healthcare Forever

July 14, 2023

Analyst Ratings for Blueprint Medicines

July 14, 2023

ETF Returns: Mid-Cap Winners And Losers

June 28, 2023

What Will AbbVie Buy Next?

June 28, 2023

Analyst Expectations for Blueprint Medicines's Future

June 14, 2023

3 Small-Cap Drug Stocks to Watch as Their Clinical Trials End Soon

June 12, 2023

Why Amedisys Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session

June 05, 2023

EPAM Systems, Amyris, Blueprint Medicines And Other Big Stocks Moving Lower On Monday

June 05, 2023

Benzinga's Top Ratings Upgrades, Downgrades For June 5, 2023

June 05, 2023

US Stocks Mixed; SAIC Posts Upbeat Results

June 05, 2023

12 Health Care Stocks Moving In Monday's Pre-Market Session

June 05, 2023

Meta Platforms To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday

June 05, 2023

This Biotech Could Soon Go Parabolic, But Should You Buy It?

June 04, 2023

Blueprint Medicines Earns Higher Price Targets Post FDA Approval: Analysts Optimistic on Ayvakit's Future

May 23, 2023

FDA OKs Blueprint Medicines' Blood Disorder Drug As First Treatment For SM Patients

May 23, 2023

Analyst Expectations for Blueprint Medicines's Future

May 23, 2023

Blueprint Medicines's Return On Capital Employed Overview

May 15, 2023

Analyst Ratings for Blueprint Medicines

May 05, 2023

Where Blueprint Medicines Stands With Analysts

April 19, 2023

16 Analysts Have This to Say About Blueprint Medicines

March 30, 2023

FDA Removes Partial Clinical Hold From Blueprint Medicines' Cancer Study

March 29, 2023

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector

March 15, 2023

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.